Semiconductor equipment makers have drawn attention from investors looking for AI infrastructure exposure without direct ownership of chipmakers. ACMR and AEHR play distinct roles in that space: one provides wafer-cleaning, electroplating, and advanced-packaging tools, while the other delivers specialized test and burn-in systems for validating AI processors. Both stocks have seen sharp price moves lately, which makes a side-by-side look useful for assessing momentum, fundamentals, and positioning in a volatile sector.
ACMR, or ACM Research, supplies single-wafer cleaning, electrochemical plating, furnace, and advanced-packaging equipment for foundry, logic, and memory production. In the latest quarter, revenue rose about 37% year over year to roughly $368 million, supported by demand for ECP and advanced-packaging tools tied to AI chips. Management lifted its full-year revenue range to about $1.24–$1.28 billion, backed by a backlog near $2.5 billion (up 88% year over year) and a 147% increase in year-to-date orders. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Even with that strength, the shares dropped from their 52-week high amid a broader semiconductor selloff linked to AI-spending worries. Reported net income fell due to a mark-to-market loss on investments, though adjusted EPS climbed 34%. Shares have since shown signs of stabilizing, and the company announced a new Oregon research-and-manufacturing site as part of a $100 million investment.
AEHR, or Aehr Test Systems, offers wafer-level and package-level burn-in and test systems to catch early-life failures in semiconductors. Its FOX and Sonoma platforms target AI processors, silicon photonics, and power devices. Revenue in the most recent fiscal quarter roughly tripled year over year to $33 million, and the company posted a net profit of about $7.2 million after a prior-year loss. Bookings topped revenue, and management raised fiscal 2027 revenue guidance to about $150 million.
The stock rallied after the report, though that followed a steep multi-week drop that wiped out much of its earlier year-to-date gain. Sentiment reflects growing AI test demand alongside concerns over customer concentration, insider selling, and a valuation above typical industry levels. The company recently added a former Meta AI infrastructure executive to its board.
The companies stand apart most clearly in scale, profitability, and valuation. ACMR is larger and profitable on an adjusted basis, with a diversified lineup and multi-billion-dollar backlog that provides solid revenue visibility. AEHR remains smaller, loss-making on a trailing twelve-month basis, and more dependent on a narrow group of AI and data-center customers, which heightens both opportunity and risk.
Valuation differences are stark: ACMR sits at a moderate earnings multiple after its pullback, while AEHR’s price-to-sales ratio exceeds the semiconductor industry average, leaving less margin for shortfalls. Growth rates also vary, with AEHR expanding faster in percentage terms from a smaller base and ACMR delivering steadier, more diversified gains. Risk profiles include China exposure for ACMR and customer concentration plus elevated valuation for AEHR.
Looking at trend consistency, profitability, backlog visibility, diversification, and relative valuation, Tickeron’s AI analysis points to ACMR as the stronger choice here. It combines sustained adjusted profitability with a record backlog, multiple growth avenues, and a more reasonable valuation following the recent decline, pointing to a balanced risk-reward setup. AEHR offers quicker growth and clear AI tailwinds but at a higher valuation premium and with greater concentration risk. Both remain sensitive to changes in AI capital-spending sentiment.
I often turn to Tickeron’s AI Trading Bots when evaluating names like these to see how systematic approaches are positioned. The platform offers a range of automated strategies across different styles, timeframes, and risk levels, which can complement manual research and highlight current market dynamics around specific tickers.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for AEHR moved below the 200-day moving average on November 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 73 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for AEHR entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 33 of 38 cases over the following month. The odds of a continued upward trend are 87%.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment